Oral Abstract Session:
172. HIV Complications and Co-Infections
Friday, October 9, 2015: 2:00 PM-3:30 PM
Room: 25--ABC

Learning Objectives:


Tracks: HIV-STD-TB

Moderators:  Roger Bedimo, MD, University of Alabama at Birmingham and Jordan Lake, MD, MSc, University of California, Los Angeles

2:00 PM
Racial Disparities Extend to Common Comorbidities among Persons in Care for HIV Infection
Kelly Richardson, PhD ; Holly Swan, PhD ; Donald Mcinnes, ScD ; Vera Yakochenko, MPH ; Leonore Okwara, MPH ; Amanda Midboe, PhD ; Barbara Bokhour, PhD ; Michael Ohl, MD, MSPH
2:12 PM
High Efficacy of Grazoprevir/Elbasvir Among HCV GT1, GT4, Or GT6 Infected Patients with HIV Co-Infection
Mark Nelson, MD ; Jurgen Rockstroh, MD ; Josep Mallolas, MD, PhD ; Christine Katlama, MD ; Ronald Nahass, MD ; Michael Saag, MD, FIDSA ; Mark Sulkowski, MD ; Anita Howe, PhD ; Peggy Hwang, MD ; Bach-Yen T. Nguyen, MD ; Janice Wahl, MD ; Eliav Barr, MD ; Michael Robertson, MD ; Barbara Haber, MD ; Heather Platt, MD
2:24 PM
Statins are Associated with Decreased Liver Disease Progression in HIV/HCV Coinfected Adults
Nouf Almaghlouth, MBBS, MPH ; Catherine Sutcliffe, PhD ; Shruti Mehta, PhD ; Richard Moore, MD, MHS, FIDSA ; Mark Sulkowski, MD
2:36 PM
Immune activation and risk of Hypertension in HIV-Infected Adults initiating antiretroviral therapy in Uganda: A nested case-control study
Samson Okello, MBchB, MMED ; Stephen Asiimwe, MBchB, MMED, MSc ; Michael Kanyesigye, BSc ; Winnie R. Muyindike, MBchB, MMED ; Yap Boum II, PhD ; Jessica Haberer, MD ; David Bangsberg, MD, MPH ; A Rain Mocello, PhD ; Jeffery N. Martin, MD, MPH ; Peter Hunt, MD ; Mark Siedner, MD MPH
3:00 PM
High Dose Fluconazole Monotherapy is Inadequate for Cerebrospinal Fluid Cryptococcal Antigen Positive (CRAG+) Persons in a CRAG Screening Program in Ethiopia
Tafese Tufa, MSc ; Abera Balcha, MD ; Fikadu Beyene, MD ; Tadele Yitbarik, MD ; Tashome Gabissa, MSc ; Anteneh Zewde, MD ; Radha Rajasingham, MD ; David Boulware, MD, MPH

CME Credits:

ACPE Credits:

ACPE Number:

See more of: Oral Abstract Session

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.